文献速递物质与行为成瘾

巴氯芬对酒精寻求与消费的影响:人类实验室研究解读

A deeper insight into how GABA-B receptor agonism via baclofen may affect alcohol seeking and consumption: lessons learned from a human laboratory investigation.
PubMed 文献 · Mol Psychiatry · 2018-10-31

巴氯芬破坏了酒精启动与自我给药间的联系,且药代动力学参数个体差异大,最大血药浓度与线索诱导的渴求及启动诱导的喜欢程度负相关。

要点

  • 巴氯芬可能通过解离初次饮酒与后续饮酒行为来减少酒精消费。
  • 巴氯芬药代动力学个体差异显著,最大血药浓度与渴求负相关。
  • 临床使用巴氯芬治疗酒精使用障碍需考虑药代动力学变异。

核心结论

  • 巴氯芬可能通过解离启动(初次饮酒)与自我给药(后续饮酒)之间的联系来发挥作用。
  • 巴氯芬药代动力学个体差异大,是治疗酒精使用障碍时需考虑的重要因素。

研究设计与样本

  • 实验包括酒精线索反应、启动和自我给药三个程序,评估渴求等主观反应并采集血样测药代动力学。

主要发现

  • 药物条件(巴氯芬vs安慰剂)与启动变量(酒精渴求:F3,9=6.03,p=0.01;酒精镇静:F3,6=7.16,p=0.01)对自我给药总量存在显著交互效应。
  • 巴氯芬药代动力学参数个体间变异显著。
  • 巴氯芬最大血浆浓度与线索诱导的酒精渴求负相关(r=-0.57,p=0.03)。
  • 巴氯芬最大血浆浓度与启动诱导的「更喜欢」评分负相关(r=-0.59,p=0.02)。

临床怎么用

  • 巴氯芬可能用于酒精使用障碍,但需关注药代动力学个体差异对疗效的影响。
  • 临床可监测巴氯芬血药浓度,其与渴求等行为指标负相关。

局限性

  • 研究周期仅一周,长期效果未知。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Previous studies suggest that GABA-B receptor agonism may represent an effective pharmacological approach to treat addictive disorders. Baclofen is a selective GABA-B receptor agonist which has been investigated as a potential treatment for alcohol use disorder. However, research is needed to understand the biobehavioral mechanisms underlying baclofen's effect on alcohol use. In the present randomized, double-blind, placebo-controlled study, thirty-four alcohol-dependent individuals were randomized to receive baclofen (30 mg/d) or placebo for a week, and then participated in a laboratory experiment consisting of three procedures: alcohol cue-reactivity, priming, and self-administration. During the experiment, craving and other subjective responses to alcohol were assessed, and blood samples were collected for pharmacokinetic measurements. The effects of baclofen on the relationships between different alcohol-related laboratory parameters were investigated. Baclofen pharmacokinetic parameters and their correlations with behavioral measures were also examined. Results showed that baclofen disrupted the link between alcohol priming and self-administration, as indicated by significant interaction effects between drug condition (baclofen vs. placebo) and some of the priming variables (alcohol craving: F3,9 = 6.03, p = 0.01; alcohol sedation: F3,6 = 7.16, p = 0.01) on the total amount of alcohol self-administered. Considerable interindividual variability in baclofen pharmacokinetic parameters was observed. Maximum plasma concentrations of baclofen negatively correlated with cue-induced alcohol craving (r = -0.57, p = 0.03) and priming-induced ratings of 'like more' (r = -0.59, p = 0.02). In conclusion, baclofen may work by dissociating the link between an initial drink (priming) and subsequent alcohol consumption (self-administration). Considerable pharmacokinetic variability is an important factor to take into account when employing baclofen as a treatment for alcohol use disorder.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Farokhnia M, Deschaine SL, Sadighi A, et al. A deeper insight into how GABA-B receptor agonism via baclofen may affect alcohol seeking and consumption: lessons learned from a human laboratory investigation. Mol Psychiatry. 2018. PMID: 30382188. doi:10.1038/s41380-018-0287-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。